2.11
0.48%
0.010
Handel nachbörslich:
2.08
-0.03
-1.42%
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
61.56%
45.54
|
28.19 | 25.37 | 27.67 | 25.12 |
Cost Of Revenue |
43.97%
21.35
|
14.83 | 14.21 | 14.06 | 12.78 |
Gross Profit |
81.09%
24.19
|
13.36 | 11.15 | 13.60 | 12.34 |
Operating Expenses
|
142.84%
84.37
|
34.74 | 32.33 | 31.05 | 41.71 |
Benefits Costs and Expenses |
61.18%
77.57
|
48.13 | 46.31 | 44.41 | 41.70 |
Costs And Expenses |
61.18%
77.57
|
48.13 | 46.31 | 44.41 | 41.70 |
Operating Income/Loss |
181.41%
-60.18
|
-21.39 | -21.17 | -17.45 | -16.59 |
Income/Loss From Continuing Operations Before Tax |
60.64%
-32.03
|
-19.94 | -20.95 | -16.74 | -16.58 |
Income Tax Expense/Benefit |
179.01%
0.128
|
-0.162 | 0.05 | 0.301 | 0.263 |
Income/Loss From Continuing Operations After Tax |
62.61%
-32.16
|
-19.78 | -21.00 | -17.04 | -16.84 |
Net Income/Loss
|
62.61%
-32.16
|
-19.78 | -21.00 | -17.04 | -16.84 |
Preferred Stock Dividends And Other Adjustments |
46.01
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
152.30K%
294.12
|
0.193 | 79.15 | 78.67 | 79.08 |
Diluted Average Shares |
152.30K%
294.12
|
0.193 | 79.15 | 78.67 | 79.08 |
Basic Earnings Per Share |
8.00%
-0.27
|
-0.25 | -0.27 | -0.22 | -0.21 |
Diluted Earnings Per Share |
8.00%
-0.27
|
-0.25 | -0.27 | -0.22 | -0.21 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
46.01
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):